Literature DB >> 25592129

Macular and peripapillary retinal nerve fibre layer thickness in patients with cyanotic congenital heart disease.

M C de Aguiar Remigio1, C T Brandt2, C C L Santos3, T E Arantes1, M I R de Aguiar4.   

Abstract

PURPOSE: To evaluate macular and retinal nerve fibre layer (RNFL) measurements in patients with cyanotic congenital heart disease (cCHD) using spectral domain optical coherence tomography (OCT). PATIENTS AND METHODS: Thirty patients with cCHD (18 females and 12 males, mean age 10.9 years) and 60 healthy controls (35 females and 25 males, mean age 11.2 years) underwent complete ophthalmologic examination and OCT measurements of macular and peripapillary RNFL thickness.
RESULTS: Patients with cCHD had significantly thinner measurements in all macular subfields compared with healthy controls (P<0.001). There was no significant difference in peripapillary RNFL thickness between the two groups, with the exception of the upper quadrant, for which thickness measurements were higher in patients with cCHD (P=0.021).
CONCLUSIONS: Patients with cCHD showed a significant decrease in macular thickness and a thickened superior quadrant RNFL thickness when compared with healthy controls. This may represent the damage caused by the effect of hypoxia.

Entities:  

Mesh:

Year:  2015        PMID: 25592129      PMCID: PMC4816373          DOI: 10.1038/eye.2014.330

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  25 in total

1.  Familial tetralogy of Fallot and glaucoma.

Authors:  S C Chen; N D'Souza
Journal:  Am J Med Genet       Date:  1990-09

2.  Central retinal vein occlusion in a young child with cyanotic heart disease.

Authors:  D K VanderVeen; L R Pasquale; A B Fulton
Journal:  Arch Ophthalmol       Date:  1997-08

3.  The changes in the circulation after birth. Their importance in congenital heart disease.

Authors:  A M Rudolph
Journal:  Circulation       Date:  1970-02       Impact factor: 29.690

Review 4.  The transition from fetal to neonatal circulation: normal responses and implications for infants with heart disease.

Authors:  A H Friedman; J T Fahey
Journal:  Semin Perinatol       Date:  1993-04       Impact factor: 3.300

Review 5.  Coloboma and other ophthalmologic anomalies in Kabuki syndrome: distinction from charge association.

Authors:  Jeffrey E Ming; Karen L Russell; Lynn Bason; Donna M McDonald-McGinn; Elaine H Zackai
Journal:  Am J Med Genet A       Date:  2003-12-15       Impact factor: 2.802

6.  Ocular pathology in congenital heart disease.

Authors:  A M Mansour; F F Bitar; E I Traboulsi; K M Kassak; M Y Obeid; A Megarbane; H I Salti
Journal:  Eye (Lond)       Date:  2005-01       Impact factor: 3.775

Review 7.  The incidence of congenital heart disease.

Authors:  Julien I E Hoffman; Samuel Kaplan
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

8.  Retinal vascular abnormalities in patients with coarctation of the aorta.

Authors:  K J Johns; J A Johns; S S Feman
Journal:  Arch Ophthalmol       Date:  1991-09

9.  The association of congenital ptosis and congenital heart disease.

Authors:  D C Larned; J C Flanagan; L E Nelson; R D Harley; T W Wilson
Journal:  Ophthalmology       Date:  1986-04       Impact factor: 12.079

Review 10.  The eye and the heart.

Authors:  Josef Flammer; Katarzyna Konieczka; Rosa M Bruno; Agostino Virdis; Andreas J Flammer; Stefano Taddei
Journal:  Eur Heart J       Date:  2013-02-10       Impact factor: 29.983

View more
  2 in total

1.  Compensation for Reflectance Variation in Vessel Density Quantification by Optical Coherence Tomography Angiography.

Authors:  Simon S Gao; Yali Jia; Liang Liu; Miao Zhang; Hana L Takusagawa; John C Morrison; David Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-08-01       Impact factor: 4.799

2.  Ocular Alterations Associated with Primary Congenital Heart Disease - A Cross-sectional Study.

Authors:  Manuel A P Vilela; Carina G Colossi; Henrique P Freitas; Giulia Del Valle; Lúcia C Pellanda
Journal:  Middle East Afr J Ophthalmol       Date:  2020-04-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.